Advancing Women’s Health by Centering Female Sexual Pleasure as Biomedical Science

We develop the scientific foundations required to measure, protect, and restore female sexual pleasure, with a focus on bulboclitoral neurovascular biology, menopause-associated tissue remodeling, and radiation-related injury.  By treating sexual function as a biological outcome rather than an afterthought, our work addresses a long-standing gap in women’s health research and cancer survivorship care.

What has Been Missing From Women’s Health Research

For decades, women’s sexual health has been under-researched, with female sexual pleasure rarely treated as a measurable biological outcome.  Key genitopelvic organs, including the bulboclitoris, have been excluded from anatomical atlases, imaging protocols, and treatment planning frameworks.  Menopause has often been treated as a confounder rather than a core biological transition shaping tissue vulnerability.  These omissions have led to preventable injury and incomplete care. 

Our research contributes to the next era of women’s health by addressing these gaps with biological precision, rigorous measurement, and clinically actionable frameworks. 

We investigate how cancer therapies and endocrine transitions remodel female genital neurovascular tissue, leading to predictable and preventable losses in sexual function.  

Our Key Research Areas

1. Bulboclitoris and Female Erectile Tissue Biology
2. Menopause-Associated Neurovascular Remodeling
3. Radiation Injury and Oncosexual Survivorship

Vaginal hydrogels to prevent scarring

Non-opioid mucosal analgesics

Multi-scale informatics

Standardization of anatomic contours

Female and LGBTQ+ oncosexual health care

Advanced pelvic imaging

Our research has five major goals:

#1 To transform the paradigm of oncosexual health in female and LGBTQ+ persons

#2 To redefine sexual organs at risk in genitopelvic and breast radiotherapy, including the bulboclitoris and neurovasculature, nipple‑areolar complex, and anal/prostate structures

#3 To decode mechanisms of radiation injury and resilience across menopause, sex, HIV status, and other dimensions of inequity using advanced imaging, spatial transcriptomics, and radiomics.

#4 To design and test new interventions—such as estrogen‑eluting vaginal hydrogels and other engineered solutions—to prevent and reverse radiation‑induced and menopause-related sexual toxicities.

#5 To advance LGBTQ+‑inclusive oncosexual health, generating data and tools that center pleasure, function, and autonomy for all survivors.